{"transactions":[{"id":2262,"issuer":{"id":1711,"kind":"organization","name":"GE HealthCare Technologies Inc.","symbol":"GEHC"},"owners":[{"id":1728,"kind":"person","name":"Bankes Jeannette","position":1,"cik":"0001920839","reported_name":"Bankes Jeannette","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Patient Care Solutions"}}],"security":"Common Stock, par value $0.01 per share","published_at":"2026-09-03T20:16:42.000Z","date":"2026-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1064,"price":71.23,"value":75788.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":37293,"source":{"system":"sec-edgar","filing":"0001920839-26-000007","document":"wk-form4_1788466599.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1932393/000192083926000007/wk-form4_1788466599.xml","form_type":"4"}},{"id":772398,"issuer":{"id":1711,"kind":"organization","name":"GE HealthCare Technologies Inc.","symbol":"GEHC"},"owners":[{"id":1728,"kind":"person","name":"Bankes Jeannette","position":1,"cik":"0001920839","reported_name":"Bankes Jeannette","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Patient Care Solutions"}}],"security":"Common Stock, par value $0.01 per share","published_at":"2026-05-19T20:04:28.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":5535,"price":62.67,"value":346878.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":38357,"source":{"system":"sec-edgar","filing":"0001920839-26-000004","document":"wk-form4_1779221065.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1920839/000192083926000004/wk-form4_1779221065.xml","form_type":"4"}},{"id":862087,"issuer":{"id":1711,"kind":"organization","name":"GE HealthCare Technologies Inc.","symbol":"GEHC"},"owners":[{"id":1728,"kind":"person","name":"Bankes Jeannette","position":1,"cik":"0001920839","reported_name":"Bankes Jeannette","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Patient Care Solutions"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-04T21:27:18.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":18038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029."}],"balance_after":18038,"derivative":{"exercise_price":80.16,"expiration_date":"2036-03-02","underlying":"Common Stock, par value $0.01 per share","underlying_shares":18038},"source":{"system":"sec-edgar","filing":"0001920839-26-000002","document":"wk-form4_1772659635.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1920839/000192083926000002/wk-form4_1772659635.xml","form_type":"4"}},{"id":862086,"issuer":{"id":1711,"kind":"organization","name":"GE HealthCare Technologies Inc.","symbol":"GEHC"},"owners":[{"id":1728,"kind":"person","name":"Bankes Jeannette","position":1,"cik":"0001920839","reported_name":"Bankes Jeannette","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Patient Care Solutions"}}],"security":"Common Stock, par value $0.01 per share","published_at":"2026-03-04T21:27:18.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":6861,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. (\"GE HealthCare\") common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029."}],"balance_after":43892,"source":{"system":"sec-edgar","filing":"0001920839-26-000002","document":"wk-form4_1772659635.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1920839/000192083926000002/wk-form4_1772659635.xml","form_type":"4"}},{"id":1143121,"issuer":{"id":1711,"kind":"organization","name":"GE HealthCare Technologies Inc.","symbol":"GEHC"},"owners":[{"id":1728,"kind":"person","name":"Bankes Jeannette","position":1,"cik":"0001920839","reported_name":"Bankes Jeannette","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Patient Care Solutions"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-05-19T20:27:53.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":18754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2026, 33% will become exercisable on September 1, 2027, and 34% will become exercisable on September 1, 2028."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2026, 33% will become exercisable on September 1, 2027, and 34% will become exercisable on September 1, 2028."}],"balance_after":18754,"derivative":{"exercise_price":72.91,"expiration_date":"2035-05-15","underlying":"Common Stock, par value $0.01 per share","underlying_shares":18754},"source":{"system":"sec-edgar","filing":"0001920839-25-000007","document":"wk-form4_1747686466.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1920839/000192083925000007/wk-form4_1747686466.xml","form_type":"4"}},{"id":1143120,"issuer":{"id":1711,"kind":"organization","name":"GE HealthCare Technologies Inc.","symbol":"GEHC"},"owners":[{"id":1728,"kind":"person","name":"Bankes Jeannette","position":1,"cik":"0001920839","reported_name":"Bankes Jeannette","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Patient Care Solutions"}}],"security":"Common Stock, par value $0.01 per share","published_at":"2025-05-19T20:27:53.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":6857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. (\"GE HealthCare\") common stock."},{"field":"shares","element":"transactionShares","label":"F3","text":"Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2026, 33% will vest on September 1, 2027, and 34% will vest on September 1, 2028."}],"balance_after":37031,"source":{"system":"sec-edgar","filing":"0001920839-25-000007","document":"wk-form4_1747686466.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1920839/000192083925000007/wk-form4_1747686466.xml","form_type":"4"}},{"id":1143119,"issuer":{"id":1711,"kind":"organization","name":"GE HealthCare Technologies Inc.","symbol":"GEHC"},"owners":[{"id":1728,"kind":"person","name":"Bankes Jeannette","position":1,"cik":"0001920839","reported_name":"Bankes Jeannette","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Patient Care Solutions"}}],"security":"Common Stock, par value $0.01 per share","published_at":"2025-05-19T20:27:53.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":30174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. (\"GE HealthCare\") common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Award of restricted stock units with respect to GE HealthCare common stock, of which 50% will vest on May 15, 2026, and 50% will vest on May 15, 2027."}],"balance_after":30174,"source":{"system":"sec-edgar","filing":"0001920839-25-000007","document":"wk-form4_1747686466.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1920839/000192083925000007/wk-form4_1747686466.xml","form_type":"4"}},{"id":1427016,"issuer":{"id":88164,"kind":"organization","name":"ATRION CORP","symbol":"ATRI"},"owners":[{"id":1728,"kind":"person","name":"Bankes Jeannette","position":1,"cik":"0001920839","reported_name":"Bankes Jeannette","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2024-08-21T16:11:01.000Z","date":"2024-08-21","kind":"disposition_to_issuer","planned":false,"acquired":true,"shares":312.51,"price":460,"value":143754.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of May 28, 2024, by and among Nordson Corporation, Alpha Medical Merger Sub, Inc., a wholly owned subsidiary of Nordson, and Atrion Corporation. At the effective time of the Merger, (i) each issued and outstanding share of common stock and (ii) each restricted stock unit, performance-based stock unit and deferred stock unit, were thereupon canceled and converted into the right to receive $460.00 in cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of May 28, 2024, by and among Nordson Corporation, Alpha Medical Merger Sub, Inc., a wholly owned subsidiary of Nordson, and Atrion Corporation. At the effective time of the Merger, (i) each issued and outstanding share of common stock and (ii) each restricted stock unit, performance-based stock unit and deferred stock unit, were thereupon canceled and converted into the right to receive $460.00 in cash."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of May 28, 2024, by and among Nordson Corporation, Alpha Medical Merger Sub, Inc., a wholly owned subsidiary of Nordson, and Atrion Corporation. At the effective time of the Merger, (i) each issued and outstanding share of common stock and (ii) each restricted stock unit, performance-based stock unit and deferred stock unit, were thereupon canceled and converted into the right to receive $460.00 in cash."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"common stock","underlying_shares":312.51},"source":{"system":"sec-edgar","filing":"0001920839-24-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/701288/000192083924000002/primary_doc.xml","form_type":"4"}},{"id":1427015,"issuer":{"id":88164,"kind":"organization","name":"ATRION CORP","symbol":"ATRI"},"owners":[{"id":1728,"kind":"person","name":"Bankes Jeannette","position":1,"cik":"0001920839","reported_name":"Bankes Jeannette","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"common stock","published_at":"2024-08-21T16:11:01.000Z","date":"2024-08-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":186,"price":460,"value":85560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of May 28, 2024, by and among Nordson Corporation, Alpha Medical Merger Sub, Inc., a wholly owned subsidiary of Nordson, and Atrion Corporation. At the effective time of the Merger, (i) each issued and outstanding share of common stock and (ii) each restricted stock unit, performance-based stock unit and deferred stock unit, were thereupon canceled and converted into the right to receive $460.00 in cash."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001920839-24-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701288/000192083924000002/primary_doc.xml","form_type":"4"}},{"id":1504639,"issuer":{"id":88164,"kind":"organization","name":"ATRION CORP","symbol":"ATRI"},"owners":[{"id":1728,"kind":"person","name":"Bankes Jeannette","position":1,"cik":"0001920839","reported_name":"Bankes Jeannette","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2024-05-23T12:19:51.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit was awarded under the Atrion Corporation 2021 Equity Incentive Plan and in accordance with the Issuers Director Compensation Program and represents the right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The deferral period for the deferred stock units lapses on the one-year anniversary of the grant date or such earlier date as set forth in the award agreement and will be settled in shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The deferral period for the deferred stock units lapses on the one-year anniversary of the grant date or such earlier date as set forth in the award agreement and will be settled in shares of the Issuer's common stock."}],"balance_after":311,"derivative":{"underlying":"common stock","underlying_shares":311},"source":{"system":"sec-edgar","filing":"0001920839-24-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701288/000192083924000001/primary_doc.xml","form_type":"4"}},{"id":1775852,"issuer":{"id":88164,"kind":"organization","name":"ATRION CORP","symbol":"ATRI"},"owners":[{"id":1728,"kind":"person","name":"Bankes Jeannette","position":1,"cik":"0001920839","reported_name":"Bankes Jeannette","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"common stock","published_at":"2023-09-21T11:06:59.000Z","date":"2023-09-20","kind":"grant","planned":false,"acquired":true,"shares":186,"price":444.03,"value":82589.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Issuer's director compensation policy provides for a grant to the Reporting Person of an annual award of common stock in an amount equal to $124,000.  On September 20, 2023, the Compensation Committee granted an award to Ms. Jeannette Bankes in an amount equal to $82,666.67 which is the pro rated portion of the annual amount for the remaining portion of the year until the Annual Stockholders meeting."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of shares of common stock issued for the award described above was based on the closing price per share of the Issuer's common stock on September 20, 2023, or $444.03."}],"balance_after":186,"source":{"system":"sec-edgar","filing":"0001920839-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701288/000192083923000002/primary_doc.xml","form_type":"4"}},{"id":1929072,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":1728,"kind":"person","name":"Bankes Jeannette","position":1,"cik":"0001920839","reported_name":"Bankes Jeannette","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-04T23:56:25.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":19333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of Issuer Common Stock granted under the Issuer's 2006 Stock Option Plan, 2016 Equity Incentive Plan or 2017 Equity Incentive Plan or pursuant to the \"inducement\" grant exception under Rule 5635(c)(4) of the Nasdaq Listing Rules (collectively, the \"Issuer Stock Plans\", and each such option, an \"Issuer Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Issuer Option and (2) the aggregate number of shares of Issuer Common Stock issuable upon exercise of such Issuer Option, less applicable taxes and authorized deductions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of Issuer Common Stock granted under the Issuer's 2006 Stock Option Plan, 2016 Equity Incentive Plan or 2017 Equity Incentive Plan or pursuant to the \"inducement\" grant exception under Rule 5635(c)(4) of the Nasdaq Listing Rules (collectively, the \"Issuer Stock Plans\", and each such option, an \"Issuer Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Issuer Option and (2) the aggregate number of shares of Issuer Common Stock issuable upon exercise of such Issuer Option, less applicable taxes and authorized deductions."}],"balance_after":0,"derivative":{"exercise_price":3.95,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":19333},"source":{"system":"sec-edgar","filing":"0001251769-23-000029","document":"wf-form4_168065257439626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1920839/000125176923000029/wf-form4_168065257439626.xml","form_type":"4"}},{"id":1929071,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":1728,"kind":"person","name":"Bankes Jeannette","position":1,"cik":"0001920839","reported_name":"Bankes Jeannette","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-04T23:56:25.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9533,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of Issuer Common Stock granted under the Issuer's 2006 Stock Option Plan, 2016 Equity Incentive Plan or 2017 Equity Incentive Plan or pursuant to the \"inducement\" grant exception under Rule 5635(c)(4) of the Nasdaq Listing Rules (collectively, the \"Issuer Stock Plans\", and each such option, an \"Issuer Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Issuer Option and (2) the aggregate number of shares of Issuer Common Stock issuable upon exercise of such Issuer Option, less applicable taxes and authorized deductions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of Issuer Common Stock granted under the Issuer's 2006 Stock Option Plan, 2016 Equity Incentive Plan or 2017 Equity Incentive Plan or pursuant to the \"inducement\" grant exception under Rule 5635(c)(4) of the Nasdaq Listing Rules (collectively, the \"Issuer Stock Plans\", and each such option, an \"Issuer Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Issuer Option and (2) the aggregate number of shares of Issuer Common Stock issuable upon exercise of such Issuer Option, less applicable taxes and authorized deductions."}],"balance_after":0,"derivative":{"exercise_price":5.3,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":9533},"source":{"system":"sec-edgar","filing":"0001251769-23-000029","document":"wf-form4_168065257439626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1920839/000125176923000029/wf-form4_168065257439626.xml","form_type":"4"}},{"id":1929070,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":1728,"kind":"person","name":"Bankes Jeannette","position":1,"cik":"0001920839","reported_name":"Bankes Jeannette","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-04T23:56:25.000Z","date":"2023-04-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17641,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 29, 2022, among the Issuer, Boston Scientific Corporation (\"Parent\") and Textile Merger Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Merger Sub\"), including the consummation of the merger between the Issuer and Merger Sub on April 4, 2023 (the \"Merger\") at the effective time of the Merger (the \"Effective Time\"), each outstanding restricted stock unit award granted under any Issuer Stock Plan (each, an \"Issuer RSU\"), whether vested but unsettled or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the right to receive $10.00 in cash, without interest (the \"Merger Consideration\"), less applicable taxes and authorized deductions [footnote continues in footnote 2 below]"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"and (2) the aggregate number of shares of Issuer common stock, par value $0.001 per share (\"Issuer Common Stock\") underlying such Issuer RSU, less applicable taxes and authorized deductions."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001251769-23-000029","document":"wf-form4_168065257439626.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1920839/000125176923000029/wf-form4_168065257439626.xml","form_type":"4"}},{"id":2230300,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":1728,"kind":"person","name":"Bankes Jeannette","position":1,"cik":"0001920839","reported_name":"Bankes Jeannette","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T01:19:26.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":19333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19333,"derivative":{"exercise_price":3.95,"exercise_date":"2023-06-14","expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":19333},"source":{"system":"sec-edgar","filing":"0001251769-22-000058","document":"wf-form4_165542875118481.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1920839/000125176922000058/wf-form4_165542875118481.xml","form_type":"4"}},{"id":2230299,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":1728,"kind":"person","name":"Bankes Jeannette","position":1,"cik":"0001920839","reported_name":"Bankes Jeannette","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T01:19:26.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":9533,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9533,"derivative":{"exercise_price":5.3,"exercise_date":"2023-04-01","expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":9533},"source":{"system":"sec-edgar","filing":"0001251769-22-000058","document":"wf-form4_165542875118481.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1920839/000125176922000058/wf-form4_165542875118481.xml","form_type":"4"}},{"id":2230298,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":1728,"kind":"person","name":"Bankes Jeannette","position":1,"cik":"0001920839","reported_name":"Bankes Jeannette","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T01:19:26.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":14224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the grant of RSUs. Each RSU provides the Reporting Person with a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the one year anniversary of the grant date."}],"balance_after":17641,"source":{"system":"sec-edgar","filing":"0001251769-22-000058","document":"wf-form4_165542875118481.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1920839/000125176922000058/wf-form4_165542875118481.xml","form_type":"4"}},{"id":2230297,"issuer":{"id":114713,"kind":"organization","name":"Apollo Endosurgery, Inc.","symbol":"APEN"},"owners":[{"id":1728,"kind":"person","name":"Bankes Jeannette","position":1,"cik":"0001920839","reported_name":"Bankes Jeannette","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T01:19:26.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":3417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of Restricted Stock Units (\"RSUs\"). Each RSU provides the Reporting Person with a contingent right to receive one share of the Issuer's common stock. The RSUs vest on April 1, 2023."}],"balance_after":3417,"source":{"system":"sec-edgar","filing":"0001251769-22-000058","document":"wf-form4_165542875118481.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1920839/000125176922000058/wf-form4_165542875118481.xml","form_type":"4"}}]}